Targeted noninvasive imaging of EGFR-expressing orthotopic pancreatic cancer using multispectral optoacoustic tomography

Cancer Research

Volumn 74, Issue 21, 2014, Pages 6271-6279

  Hudson, Shanice V ^a   Huang, Justin S ^a   Yin, Wenyuan ^a   Albeituni, Sabrin ^a   Rush, Jamie ^a   Khanal, Anil ^a   Yan, Jun ^a   Ceresa, Brian P ^a   Frieboes, Hermann B ^a,b   McNally, Lacey R ^a  

^a University of Louisville School of Medicine   (United States)

^b University of Louisville   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CONTRAST MEDIUM; EGF 750; EPIDERMAL GROWTH FACTOR RECEPTOR; UNCLASSIFIED DRUG; EGFR PROTEIN, HUMAN; FLUORESCENT DYE;

ANIMAL MODEL; ARTICLE; BIOLUMINESCENCE; CANCER CELL LINE; CONTROLLED STUDY; EARLY DIAGNOSIS; FEASIBILITY STUDY; FLOW CYTOMETRY; FLUORESCENCE IMAGING; HIGH RESOLUTION COMPUTER TOMOGRAPHY; HUMAN; HUMAN CELL; IMAGE RECONSTRUCTION; IMMUNOBLOTTING; IMMUNOCYTOCHEMISTRY; LIGAND BINDING; LIGHT SCATTERING; METASTASIS POTENTIAL; MOUSE; MULTISPECTRAL OPTOACOUSTIC TOMOGRAPHY; NEAR INFRARED SPECTROSCOPY; NON INVASIVE PROCEDURE; NONHUMAN; PANCREAS CANCER; PHOTOACOUSTIC TOMOGRAPHY; PHOTON; PROTEIN EXPRESSION; TUMOR VOLUME; UPREGULATION; WESTERN BLOTTING; ANIMAL; BIOSYNTHESIS; DIAGNOSTIC USE; DRUG SCREENING; GENETICS; ISOLATION AND PURIFICATION; PANCREAS TUMOR; PATHOLOGY; PHOTOACOUSTICS; PROCEDURES; RADIOGRAPHY; TOMOGRAPHY;

ANIMALS; FLUORESCENT DYES; HUMANS; MICE; PANCREATIC NEOPLASMS; PHOTOACOUSTIC TECHNIQUES; RECEPTOR, EPIDERMAL GROWTH FACTOR; TOMOGRAPHY; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84909609671     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-14-1656     Document Type: Article

References (50)

1. Pocard M, Tsukui H, Salmon RJ, Dutrillaux B, Poupon MF. Efficiency of orthotopic xenograft models for human colon cancers. In Vivo 1996; 10:463-9.
2. Kagadis GC, Loudos G, Katsanos K, Langer SG, Nikiforidis GC. In vivo small animal imaging: current status and future prospects. Med Phys 2010;37:6421-42.
3. Condeelis J, Weissleder R. In vivo imaging in cancer. Cold Spring Harb Perspect Biol 2010;2:a003848.
4. Tangney M, Francis KP. In vivo optical imaging in gene & cell therapy. Curr Gene Ther 2012;12:2-11.
5. Lutzweiler C, Razansky D. Optoacoustic imaging and tomography: reconstruction approaches and outstanding challenges in image performance and quantification. Sensors 2013;13:7345-84.
6. Ntziachristos V, Razansky D.Molecular imaging bymeans ofmultispectral optoacoustic tomography (MSOT). Chem Rev 2010;110:2783-94.
7. Razansky D, Distel M, Vinegoni C, Ma R, Perrimon N, Köster RW, et al. Multispectral opto-acoustic tomography of deep-seated fluorescent proteins in vivo. Nat Photonics 2009;3:412-7.
8. Ntziachristos V. Going deeper than microscopy: the optical imaging frontier in biology. Nature Methods 2010;7:603-14.
9. Razansky D, Deliolanis NC, Vinegoni C, Ntziachristos V. Deep tissue optical and optoacoustic molecular imaging technologies for preclinical research and drug discovery. Curr Pharm Biotechnol 2012; 13:504-22.
10. Buehler A, Herzog E, Ale A, Smith BD, Ntziachristos V, Razansky D. High resolution tumor targeting in living mice by means of multispectral optoacoustic tomography. EJNMMI Res 2012;2:14.
11. Dinneen JL, Ceresa BP. Expression of dominant negative rab5 in HeLa cells regulates endocytic trafficking distal from the plasma membrane. Experimental Cell Res 2004;294:509-22.
12. Ceresa BP, Bahr SJ. Rab7 activity affects epidermal growth factor: epidermal growth factor receptor degradation by regulating endocytic trafficking from the late endosome. J Biol Chem 2006;281: 1099-1106.
13. Ghislat G, Aguado C, Knecht E. Annexin A5 stimulates autophagy and inhibits endocytosis. J Cell Sci 2012;125:92-107.
14. Ke S, Wen X, Gurfinkel M, Charnsangavej C, Wallace S, Sevick-Muraca EM, et al. Near-infrared optical imaging of epidermal growth factor receptor in breast cancer xenografts. Cancer Res 2003;63: 7870-5.
15. Sihver W, Pietzsch J, Krause M, Baumann M, Steinbach J, Pietzsch HJ. Radiolabeled cetuximab conjugates for EGFR targeted cancer diagnostics and therapy. Pharmaceuticals 2014;7:311-38.
16. Samkoe KS, Hextrum SK, Pardesi O, O'Hara JA, Hasan T, Pogue BW. Specific binding of molecularly targeted agents to pancreas tumors and impact on observed optical contrast. Proc SPIE 7568, Imaging, Manipulation, and Analysis of Biomolecules, Cells, and Tissues VIII 2010;75680H.
17. Panchuk-Voloshina N, Haugland RP, Bishop-Stewart J, Bhalgat MK, Millard PJ, Mao F, et al. Alexa dyes, a series of new fluorescent dyes that yield exceptionally bright, photostable conjugates. J Histochem Cytochem 1999;47:1179-88.
18. Hermanson GT, editor. Bioconjugate techniques, 2nd ed. London: Elsevier; 2008.
19. Hemminki A, Dmitriev I, Liu B, Desmond RA, Alemany R, Curiel DT. Targeting oncolytic adenoviral agents to the epidermal growth factor pathway with a secretory fusion molecule. Cancer Res 2001;61: 6377-81.
20. Pereboeva L, Komarova S, Roth J, Ponnazhagan, Curiel DT. Targeting EGFR with metabolically biotinyated fiber-mosaic adenovirus. Gene Therapy 2007;14:627-37.
21. Leath CA III, Kataram M, Bhagavatula P, Gopalkrishnan RV, Dent P, Fisher PB, et al. Infectivity enhanced adenoviral-mediated mda-7/IL-24 gene therapy for ovarian carcinoma. Gynecologic Oncol 2004;94: 352-62.
22. Ju WD, Velu TJ, Vass WC, Papageorge AG, Lowy DR. Tumorigenic transformation of NIH 3T3 cells by the autocrine synthesis of transforming growth factor alpha. New Biol 1991;3:380-8.
23. Xu H, Yu Y, Marciniak D, Rishi AK, Sarkar FH, Kucuk O, et al. Epidermal growth factor receptor (EGFR)-related protein inhibits multiple members of the EGFR family in colon and breast cancer cells. Mol Cancer Ther 2005;4:435-42.
24. Rush JS, Ceresa BP. RAB7 and TSG101 are required for the constitutive recycling of unliganded EGFRs via distinct mechanisms. Mol Cell Endocrinol 2013;381:188-97.
25. McNally LR, Welch DR, Beck BH, Stafford LJ, Long JW, Sellers JC. KISS1 over-expression suppresses metastasis of pancreatic adenocarcinoma in a xenograft mouse model. Clin Exp Metastasis 2010; 27:591-600.
26. Razansky D, Buehler A, Ntziachristos V. Volumetric real-time multispectral optoacoustic tomography of biomarkers. Nature Protocols 2011;6:1121-9.
27. Rush JS, Quinalty LM, Engelman L, Sherry DM, Ceresa BP. Endosomal accumulation of the activated epidermal growth factor receptor (EGFR) induces apoptosis. J Biol Chem 2012;287:712-22.
28. Kawamoto T, Sato JD, Le A, Polikoff J, Sato GH, Mendelsohn J. Growth stimulation of A431 cells by epidermal growth factor: identification of high-affinity receptors for epidermal growth factor by an anti-receptor monoclonal antibody. Proc Natl Acad Sci U S A 1983; 80:1337-41.
29. Razansky D, Baeten J, Ntziachristos V. Sensitivity of molecular target detection by multispectral optoacoustic tomography (MSOT). Med Phys 2009;36:939-45.
30. Herzog E, Taruttis A, Beziere N, Lutich AA, Razansky D, Ntziachristos V. Optical imaging of cancer heterogeneity with multispectral optoacoustic tomography. Radiology 2012;263:461-8.
31. Burton NC, Patel M, Morscher S, Driessen WHP, Claussen J, Beziere N, et al. Multispectral opto-acoustic tomography (MSOT) of the brain and glioblastoma characterization. NeuroImage 2013;65:522-8.
32. Taruttis A, Herzog E, Razansky D, Ntziachristos V. Real-time imaging of cardiovascular dynamics and circulating gold nanorods with multispectral optoacoustic tomography. Opt Express 2010;18: 19592-602.
33. Ma R, Taruttis A, Ntziachristos V, Razansky D. Multispectral optoacoustic tomography (MSOT) scanner for whole-body small animal imaging. Opt Express 2009;17:21414-26.
34. Wang X, Xie X, Ku G, Wang LV, Stoica G. Noninvasive imaging of hemoglobin concentration and oxygenation in the rat brain using highresolution photoacoustic tomography. J Biomed Opt 2006;11:024015.
35. Taruttis A, Morscher S, Burton NC, Razansky D, Ntziachristos V. Fast multispectral optoacoustic tomography (MSOT) for dynamic imaging of pharmacokinetics and biodistribution in multiple organs. PLoS ONE 2012;7:e30491.
36. Luke GP, Yeager D, Emelianov SY. Biomedical applications of photoacoustic imaging with exogenous contrast agents. Ann Biomed Eng 2012;40:422-37.
37. Razansky D, Harlaar NJ, Hillebrands JL, Taruttis A, Herzog E, Zeebregts CJ, et al. Multispectral optoacoustic tomography of matrix metalloproteinase activity in vulnerable human carotid plaques. Mol Imaging Biol 2012;14:277-85.
38. Troiani T, Martinelli E, Capasso A, Morgillo F, Orditura M, De Vita F, et al. Targeting EGFR in pancreatic cancer treatment. Curr Drug Targets 2012;13:802-10.
39. Oliveira-Cunha M, Newman WG, Siriwardena AK. Epidermal growth factor receptor in pancreatic cancer. Cancers 2011;3:1513-26.
40. Tobita K, Kijima H, Dowaki S, Kashiwagi H, Ohtani Y, Oida Y, et al. Epidermal growth factor receptor expression in human pancreatic cancer: Significance for liver metastasis. Int J Mol Med 2003;11: 305-9.
41. Bull Phelps SL, Schorge JO, Peyton MJ, Shigematsu H, Xiang LL, Miller DS, et al. Implications of EGFR inhibition in ovarian cell proliferation. Gynecol Oncol 2008;109:411-7.
42. Buehler A, Kacprowicz M, Taruttis A, Ntziachristos V. Real-time handheld multispectral optoacoustic imaging. Optics Letters 2013;38: 1404-6.
43. Dean-Ben XL, Razansky D. Portable spherical array probe for volumetric real-time optoacoustic imaging at centimeter-scale depths. Optics Express 2013;21:28062-71.
44. Dean-Ben XL, Razansky D. Functional optoacoustic human angiography with handheld video rate three dimensional scanner. Photoacoustics 2013;1:68-73.
45. Cook N, Frese KK, Moore M. Assessing the role of the EGF receptor in the development and progression of pancreatic cancer. Gastrointest Cancer: Targets and Therapy 2014;4:23-37.
46. Chong CR, Jänne PA. The quest to overcome resistance to EGFRtargeted therapies in cancer. Nat Med 2013;19:1389-1400.
47. Rembielak A, Green M, Saleem A, Price P. Diagnostic and therapeutic imaging in oncology. Medicine 2011;39:693-7.
48. Kim TH, Lee S, Chen X. Nanotheranostics for personalized medicine. Expert Rev Mol Diagn 2013;13:257-69.
49. Rizzo LY, Theek B, Storm G, Kiessling F, Lammers T. Recent progress in nanomedicine: Therapeutic, diagnostic and theranostic applications. Curr Opin Biotechnol 2013;24:1159-66.
50. Bao C, Beziere N, del Pino P, Pelaz B, Estrada G, Tian F , et al. Gold nanoprisms as optoacoustic signal nanoamplifiers for in vivo bioimaging of gastrointestinal cancers. Small 2013;9:68-74.